California-based real-world data platform atropos health Medical data analysis company announces Arcadia joins the company’s health portfolio, giving Arcadia’s provider customers and life sciences users access to Atropos‘ products.
Atropos Health provides AI innovation, evidence generation, enhanced analytics, and data evaluation to help physicians access real-world evidence to guide clinical decision-making and research.
The company’s clinical informatics service, known as Green Button, provides publication-grade observational research reports based on users‘ clinical questions. And it offers Geneva OS, an operating system for rapidly obtaining medical evidence across vast networks of real-world data.
Boston-based Arcadia is a healthcare data platform that provides providers with tools for network management, payment management, process improvements around visit access and referrals, and prior authorization monitoring.
Through this partnership, Arcadia will join Atropos‘ Evidence Network, giving users access to Atropos‘ portfolio of applications that support clinical decision-making in value-based care.
Atropos life sciences users can also leverage Arcadia’s longitudinal research datasets to conduct real-world evidence studies.
“A key element of value-based care is optimizing clinical decision-making when existing published evidence is insufficient,” said Brigham Hyde, CEO and co-founder of Atropos Health. said the doctor in a statement.
“This partnership will further empower healthcare providers to make data-driven decisions about the best clinical guidelines, care pathways, and best interventions to successfully implement value-based care and other quality initiatives.” , allowing us to rapidly generate new peer-reviewed evidence.”
bigger trends
During December, guide healthan AI-enabled value-based care provider for health systems; announced that it had acquired Arcadia’s value-based care services division and managed services organization.
The company also signed an agreement with Arcadia to utilize its data analytics platform to power its acquired products in conjunction with predictive and generative AI.
Arcadia scored in April $125 million in funding 3 years after receiving $29.5 million Growth stock investment.
Last year, Atropos Health raised funds. $14 million in Series A funding.
The company announced a number of partnerships last year, including one with Johnson & Johnson’s Janssen Research & Development to accelerate clinical development through real-world data analysis.
Atropos also partnered with clinical analytics and patient record summarization company and data sharing technology startup KAID Health. data band and healthcare data companies seek star.